Medical device manufacturer invests $110M to expand Nebraska plant, boost drug supply

(The Center Square) – A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort to restore pharmaceutical manufacturing and improve domestic supply chains.

Becton, Dickinson and Company (BD) announced this week that it will expand its facility in Columbus, Nebraska, to increase production of prefillable syringes used in biologic drugs, including GLP-1 weight loss medications like Ozempic and Wegovy. The investment is expected to create about 120 new jobs, according to a press release from the company.